Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aspira Women’s Health Inc. develops and commercializes noninvasive, AI-powered diagnostic tests for gynecologic diseases, focusing on ovarian cancer and endometriosis. Its key products include the OvaSuite tests (Ova1, Overa, OvaWatch) and pipeline assays like OVAinform and ENDOinform. Serving physicians and healthcare providers primarily in the U.S., Aspira operates a CLIA-certified lab and leverages proprietary biomarker and algorithm technologies to improve early disease detection and patient risk assessment.
This description was generated via AI from an annual report. Updated about 1 year ago.